Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00656_DB00701_nanopub.RA_W2byHuLX-MQGJzacE37OTDmm1scr80Aj-YIUQVXZwM#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00656_DB00701 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00656_DB00701 label "DDI between Trazodone and Amprenavir - The protease inhibitor, Amprenavir, may increase the efficacy/toxicity of Trazodone by inhibiting Trazodone metabolism and clearance. Monitor for changes in Trazodone efficacy/toxicity if Amprenavir is initiated, discontinued or dose changed. [drugbank_resource:DB00656_DB00701]" assertion.
- drugbank_resource:DB00656_DB00701 identifier "drugbank_resource:DB00656_DB00701" assertion.
- drugbank_resource:DB00656_DB00701 title "DDI between Trazodone and Amprenavir - The protease inhibitor, Amprenavir, may increase the efficacy/toxicity of Trazodone by inhibiting Trazodone metabolism and clearance. Monitor for changes in Trazodone efficacy/toxicity if Amprenavir is initiated, discontinued or dose changed." assertion.
- drugbank:DB00701 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00656_DB00701 assertion.
- drugbank:DB00656 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00656_DB00701 assertion.